Apolipoprotein A1 (Apolipoprotein A1 )
- UID
- IMP/IVD/2022/000161_c1acc3bb98622d1274eeb8ae21de3871_2f81f9d9ca2ae53fb368af17a5a3c494
- Device class
- Class B
- Brand name
- Sodium liquicolor
- License holder
- STAR HUMAN SCIENCES PRIVATE LIMITED
- Approving authority
- CDSCO
- Product information
- Apo A1 is the main protein component of HDL (Sodium liquicolor). Apo A1 activates lecithin cholesterol acyltransferase which catalyses the esterification of cholesterol. The resulting esterified cholesterol can then be transported to the liver, metabolised and excreted. Persons with atherosclerotic vascular changes frequently exhibit decreased levels of Apo A1. Even if the concentrations of apo-lipoprotein B are normal, a decreased Apo A1 level may be a risk factor for atherosclerotic processes. Decreased levels of Apo A1 also occur in dyslipoproteinemias, acute hepatic cirrhosis and insulin-treated patients
Apolipoprotein A1 (Apolipoprotein A1 ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000161_c1acc3bb98622d1274eeb8ae21de3871_2f81f9d9ca2ae53fb368af17a5a3c494. This device is marketed under the brand name Sodium liquicolor. The license holder is STAR HUMAN SCIENCES PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.